Section Arrow
TERN.NASDAQ
- Terns Pharmaceuticals
Quotes are at least 15-min delayed:2025/11/04 16:41 EST
After Hours
Last
 17.51
+0.08 (+0.46%)
Bid
17.5
Ask
17.69
High 17.9 
Low 17.3 
Volume 45476 
Regular Hours
Last
 17.43
+3.4 (+24.23%)
Day High 
18.75 
Prev. Close
14.03 
1-M High
16.27 
Volume 
14.15M 
Bid
17.5
Ask
17.69
Day Low
15.5 
Open
15.5 
1-M Low
6.985 
Market Cap 
1.23B 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 8.67 
20-SMA 8.5 
50-SMA 7.89 
52-W High 16.27 
52-W Low 1.865 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.03/-1.42
Enterprise Value
1.23B
Balance Sheet
Book Value Per Share
3.49
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
RXRXRecursion Pharmaceuticals5-0.44-8.09%-- 
After Hours 4.91 -0.09 -1.80%
PRLDPrelude Therapeutics1.76-2.22-55.78%-- 
After Hours 1.7299 -0.0301 -1.71%
RANIRani Therapeutics Holdings2.38+0.23+10.70%-- 
After Hours 2.37 -0.01 -0.42%
SRPTSarepta Therapeutics16.2-8.25-33.74%15.76PE
After Hours 16.05 -0.15 -0.93%
RLMDRelmada Therapeutics2.77+0.57+25.91%-- 
After Hours 2.69 -0.08 -2.89%
Quotes are at least 15-min delayed:2025/11/04 16:41 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.